Atlas FDA

MEDRAD Stellant CT Injector System with Certegra Workstation; intended for the specific purpose of injecting intravenous

FDA device recall Z-1686-2015 · posted 2015-05-28 · Terminated

Recall details

Recalling firm
Medrad Inc dba Bayer R&I
Reason for recall
The root cause investigation showed that the under-volume hazard can occur when the unit has been configured to prime with contrast, but instead primes with saline due to the configuration data not being sent to the injector head. This may create a non-optimal priming condition that could lead to under-infusion.
Action taken
Bayer Healthcare sent a Medical Device Field Corrective Action letter to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to identify any affected device. Bayer Service will schedule time to update their software free of charge. Customers with questions were instructed to contact the customer support team at 1-800-633-7237. For questions regarding this recall call 412-767-2400.
Root cause
Software design
Status
Terminated
Product code
DXT
Quantity affected
133
Distribution
Nationwide Distribution
Date initiated
2013-09-20
Date posted
2015-05-28
Date terminated
2015-06-16
Location
Indianola, PA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
MEDRAD STELLANT CT INJECTOR SYSTEM WITH P3T CARDIAC (K082905)Medrad, Inc.2009-01-12